Malignant Melanoma: Skin Cancer-Diagnosis, Prevention, and Treatment.
Ahmed B, Qadir MI, Ghafoor S.
Crit Rev Eukaryot Gene Expr. 2020;30(4):291-297. doi: 10.1615/CritRevEukaryotGeneExpr.2020028454.
Model Systems for the Study of Malignant Melanoma.
Gregg RK.
Methods Mol Biol. 2021;2265:1-21. doi: 10.1007/978-1-0716-1205-7_1.
Cutaneous melanoma: From pathogenesis to therapy (Review).
Leonardi GC, Falzone L, Salemi R, Zanghì A, Spandidos DA, Mccubrey JA, Candido S, Libra M.
Int J Oncol. 2018 Apr;52(4):1071-1080. doi: 10.3892/ijo.2018.4287. Epub 2018 Feb 27.
Atypical fibroxanthoma: A malignant tumor of the skin and soft tissue.
Rosenfeld D, Alam M, Van Tine B, Council ML.
J Am Acad Dermatol. 2020 Dec;83(6):e429-e430. doi: 10.1016/j.jaad.2020.07.022. Epub 2020 Jul 15.
[Management of malignant wounds].
Kirchberger MC, Erfurt-Berge C.
Z Gerontol Geriatr. 2020 Oct;53(6):572-576. doi: 10.1007/s00391-019-01629-w. Epub 2019 Oct 2.
Atypical Fibroxanthoma.
López L, Vélez R.
Arch Pathol Lab Med. 2016 Apr;140(4):376-9. doi: 10.5858/arpa.2014-0495-RS.
Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
Soleymani T, Aasi SZ, Novoa R, Hollmig ST.
Dermatol Clin. 2019 Jul;37(3):253-259. doi: 10.1016/j.det.2019.02.001. Epub 2019 Apr 16.
Rare emerging malignant skin tumours.
Rongioletti F, Ferreli C, Pinna AL, Atzori L.
G Ital Dermatol Venereol. 2015 Aug;150(4):407-17.
[Atypical fibroxanthoma].
Vasilyev NV, Vtorushin SV, Maltseva AA, Sannikova AV.
Arkh Patol. 2023;85(5):65-72. doi: 10.17116/patol20238505165.
The Roles of Extracellular Vesicles in Malignant Melanoma.
Cheng YC, Chang YA, Chen YJ, Sung HM, Bogeski I, Su HL, Hsu YL, Wang HD.
Cells. 2021 Oct 14;10(10):2740. doi: 10.3390/cells10102740.
